https://doi.org/10.4081/monaldi.2023.2502
Acute myocardial infarction during late COVID-19 era: patient characteristics, presentation and outcomes
Submitted: December 3, 2022
Accepted: December 15, 2022
Published: January 13, 2023
Accepted: December 15, 2022
Abstract Views: 1361
PDF: 275
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
COVID-19 pandemic has unquestionably influenced care of acute myocardial infarction (AMI). Still, its impact on patients (pts) characteristics, presentation, treatment, and outcomes remains not well established in late pandemic times. To address this issue, we performed a prospective study of type-1 AMI patients admitted in a tertiary care hospital. Pts were enrolled during 6-months in 2019 [n=122; pre-COVID-19 (PC) group] and in 2021 [n=196; late-COVID-19 (C) group]. Data was based on pts interview and review of medical records. Age and gender distribution, as well as ST/non-ST-elevation myocardial infarction (STEMI/NSTEMI) proportion and access to coronariography and revascularization were similar between groups. Group C patients presented more pre-existing established cardiovascular disease (CVD) (43% vs 30%; p=0.03); more frequent description of typical chest pain (94% vs 84%; p=0,002); higher levels of pain intensity, in a 0-10 scale (8±2 vs 7±2; p=0.02); higher frequencies of AMI complications (27% vs 15%; p=0.01) and worse Killip (K) class evolution (K≥2 in 22% C vs13% PC patients; p=0.05). In conclusion, late pandemic AMI patients presented worse in-hospital outcomes in our study, though pre-hospital and hospital care were comparable to pre-pandemic times. COVID patients had a higher burden of pre-existing established CVD and a more typical and intense symptom presentation. Therefore, it can be hypothesized that "sicker" patients continued to look for help when presenting AMI symptoms, while "less sick" patients and the ones with less typical and intense symptoms possibly avoided contact with health care services during late pandemic period.
Grave C, Gabet A, Puymirat E, et al. Myocardial infarction throughout 1 year of the COVID-19 pandemic: French nationwide study of hospitalization rates, prognosis and 90-day mortality rates. Arch Cardiovasc Dis 2021;114:768-80.
DOI: https://doi.org/10.1016/j.acvd.2021.10.008
Mefford MT, An J, Gupta N, et al. Rates of acute myocardial infarction during the COVID-19 pandemic. Perm J 2021;25:074.
DOI: https://doi.org/10.7812/TPP/21.074
Pereira H, Naber C, Wallace S, et al. Stent-Save a Life international survey on the practice of primary percutaneous coronary intervention during the COVID-19 pandemic. Rev Portug Cardiol 2022;41:221-7.
DOI: https://doi.org/10.1093/eurheartj/ehab724.1240
Jasani G, Alemayehu T, Chizmar T, Wilson L. Changes in EMS utilization in the state of Maryland during the first 6 months of the COVID-19 pandemic. Am J Disaster Med 2022;17:41-8.
DOI: https://doi.org/10.5055/ajdm.2022.0418
Burger AL, Kaufmann CC, Jäger B, et al. Direct cardiovascular complications and indirect collateral damage during the COVID-19 pandemic : A review. Wien Klin Wochenschr 2021;133:1289-97.
DOI: https://doi.org/10.1007/s00508-021-01956-2
Azul Freitas A, Baptista R, Gonçalves V, et al. Impact of SARS-CoV-2 pandemic on ST-elevation myocardial infarction admissions and outcomes in a Portuguese primary percutaneous coronary intervention center: Preliminary Data. Rev Portug Cardiol 2022;41:465-71.
DOI: https://doi.org/10.1016/j.repc.2020.10.012
Calvão J, Amador AF, Costa CMd, et al. The impact of the COVID-19 pandemic on acute coronary syndrome admissions to a tertiary care hospital in Portugal. Rev Portug Cardiol 2022;41:147-52.
DOI: https://doi.org/10.1016/j.repc.2021.01.007
Clodfelder C, Cooper S, Edwards J, et al. Delayed care in myocardial infarction and ischemic stroke patients during the COVID-19 pandemic. Am J Emerg Med 2022;54:326.e1-4.
DOI: https://doi.org/10.1016/j.ajem.2021.10.023
Guddeti RR, Yildiz M, Nayak KR, et al. Impact of COVID-19 on acute myocardial infarction care. Cardiol Clin 2022;40:345-53.
DOI: https://doi.org/10.1016/j.ccl.2022.03.004
D'Abramo M, Saltarocchi S, Vignaroli W, et al. Increased incidence of postmyocardial infarction ventricular septal defects during Covid-19 pandemic: A case series. J Card Surg 2022;37:1759-63.
DOI: https://doi.org/10.1111/jocs.16430
Oliveira L, Campante Teles R, Machado C, et al. Worrisome trends of ST-elevation myocardial infarction during the Covid-19 pandemic: Data from Portuguese centers. Rev Portug Cardiol 2022;41:465-71.
DOI: https://doi.org/10.1016/j.repc.2021.03.012
Simoni L, Alimehmeti I, Gina M, et al. Hospitalizations and in-hospital outcomes in patients with ST-elevation myocardial infarction during the coronavirus disease 2019 pandemic: The Albanian experience. Anatol J Cardiol 2022;26:118-26.
DOI: https://doi.org/10.5152/AnatolJCardiol.2021.486
Malhi N, Moghaddam N, Hosseini F, et al. Care and outcomes of ST-segment elevation myocardial infarction across multiple COVID-19 waves. Can J Cardiol 2022;38:783-91.
DOI: https://doi.org/10.1016/j.cjca.2022.01.033
Banfield WH, Elghawy O, Dewanjee A, Brady WJ. Impact of COVID-19 on emergency department management of stroke and STEMI. A narrative review. Am J Emerg Med 2022;57:91-7.
DOI: https://doi.org/10.1016/j.ajem.2022.04.033
Ryu S, Kim D, Jung LY, et al. Decreased door-to-balloon time in patients with ST-segment elevation myocardial infarction during the early COVID-19 pandemic in South Korea: An observational study. Medicine (Baltimore) 2022;101:e29596.
DOI: https://doi.org/10.1097/MD.0000000000029596
Gong X, Zhou L, Dong T, et al. Impact of COVID-19 pandemic on STEMI undergoing primary PCI treatment in Beijing, China. Am J Emerg Med 2022;53:68-72.
DOI: https://doi.org/10.1016/j.ajem.2021.11.034
Ethics Approval
The study was approved by the Ethics Committee of “Centro Hospitalar Universitário de São João / Faculdade de Medicina da Universidade do Porto” on September 21, 2021 (reference number 290/21)How to Cite
Marques, Catarina Amaral, André Cabrita, Paulo Araújo, Tânia Proença, Ricardo Pinto, Miguel Carvalho, Catarina Costa, Ana Amador, João Calvão, and Cristina Cruz. 2023. “Acute Myocardial Infarction During Late COVID-19 Era: Patient Characteristics, Presentation and Outcomes”. Monaldi Archives for Chest Disease 93 (4). https://doi.org/10.4081/monaldi.2023.2502.
Copyright (c) 2023 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Naji Kholaif, Lin Batha, Isra Elmahi, Sulaiman Alnaser, Sultan Alzaher, Norah Almallohi , Mosaad Alhussein, Dana Alhalees, Ahmed Alshehri, Transplantation of heterozygous familial hypercholesterolemia living donor liver resulting in early myocardial infarction: a possible dangerous link , Monaldi Archives for Chest Disease: Early Access
- Matteo Pernigo, Marco Triggiani, Emanuele Gavazzi, Ilaria Papa, Alberto Vaccari, Simona Fisogni, Ester Costantino, Gian Franco Pasini, Acute heart failure due to COVID-19 related myocardial injury and de novo hypertensive cardiomyopathy: a challenging diagnosis , Monaldi Archives for Chest Disease: Vol. 92 No. 1 (2022)
- Gennaro Ratti, Antonio Maglione, Emilia Biglietto, Cinzia Monda, Ciro Elettrico, Federica Ratti, Cosimo Fulgione, Mario Mallardo, Paolo Tammaro, Long term dual antiplatelet therapy after myocardial infarction: retrospective analysis in an outpatient population , Monaldi Archives for Chest Disease: Vol. 92 No. 1 (2022)
- Federico Raimondi, Stefano Centanni, Fabrizio Luppi, Stefano Aliberti, Francesco Blasi, Paola Rogliani, Claudio Micheletto, Marco Contoli, Alessandro Sanduzzi Zamparelli, Marialuisa Bocchino, Paolo Busatto, Luca Novelli, Simone Pappacena, Luca Malandrino, Giorgio Lorini, Greta Cairoli, Fabiano Di Marco, Respiratory rate-oxygenation index on the 3rd day is the best predictor of treatment failure in COVID-19 patients , Monaldi Archives for Chest Disease: Early Access
- Valeriu Plesca, Ana Ciobanu, Yuliia Sereda, Andrei Dadu, Do catastrophic costs impact treatment outcomes in people with rifampicin-resistant tuberculosis in the Republic of Moldova? , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- Alessandro Mezzani, Francesco Cacciatore, Raffaella Catanzaro, Alessandra Gualco, Daniela Guzzetti, Dario Leosco, Mauro Monelli, Franco Tarro Genta, Paolo Totaro, Egidio Traversi, Emanuela Zanelli, Pantaleo Giannuzzi, A multicenter, randomized, controlled trial on short-term feasibility and impact on functional capacity, symptoms and neurohumoral activation , Monaldi Archives for Chest Disease: Vol. 82 No. 1 (2014): Cardiac series
- Elena Zelikovna Golukhova, Inessa Viktorovna Slivneva, Andrey Lvovich Pylev, Olga Sergeevna Kozlova, Karen Valerievich Petrosyan, Denis Sergeevich Romanov, Alexander Yurievich Volkov, Optimal treatment strategies for coronary heart disease in cancer patients: a complex clinical case , Monaldi Archives for Chest Disease: Early Access
- Roberto Tramarin, Marco Ambrosetti, Stefania De Feo, Massimo Piepoli, Carmine Riccio, Raffaele Griffo, The Italian Survey on Cardiac Rehabilitation - 2008 (ISYDE-2008). Part 3. National availability and organization of cardiac rehabilitation facilities. Official report of the Italian Association for Cardiovascular Prevention, Rehabilitation and Epidemiolog , Monaldi Archives for Chest Disease: Vol. 70 No. 4 (2008): Cardiac series
- Matteo Vigna, Piero Ceriana, Mara Santomassimo, Michele Vitacca, Mauro Maniscalco, Nicolino Ambrosino, Effects of pulmonary rehabilitation in survivors of severe acute respiratory syndrome coronavirus 2. Role of vaccination , Monaldi Archives for Chest Disease: Early Access
- Cesare Greco, Rivaroxaban in non valvular atrial fibrillation: subgroups analysis , Monaldi Archives for Chest Disease: Vol. 82 No. 1 (2014): Cardiac series
<< < 7 8 9 10 11 12 13 14 15 16 > >>
You may also start an advanced similarity search for this article.
